Sánchez-Guillén M C, Argüello-García R, Garduño G, Valadez-Salazar A, Martínez-García M C, Muñoz O, Ortega-Pierres M G
Unidad de Inv. Clínica en Enfermedades Infecciosas y Parasitarias, C.M.N., I.M.S.S., México, D.F.
Arch Invest Med (Mex). 1990;21 Suppl 1:209-15.
Human amebiasis is a parasitic infection which involves asymptomatic as well as intestinal and extraintestinal symptomatic stages in individuals harbouring Entamoeba histolytica. Several factors have been proposed to explain the variability in the outcome of the disease. Among these are differences in virulence of E. histolytica strains and methods such as zymodeme analysis have been used to differentiate invasive from non invasive strains of this parasite (Sargeaunt and Williams, 1978). In order to establish a possible correlation between zymodeme analysis and serological data in human cases of amebiasis, a cross-sectional epidemiological study was carried out in the community area of Cadereyta, State of Queretaro, Mexico. In this study, fecal and serum samples from individuals were also tested by Indirect Hemagglutination assay (IHA) to determine antibody titre and by a standardized Electroimmunotransfer blot assay (EITB) for recognition of E. histolytica specific antigens. Zymodemes were determined in a total of 81 samples. Of these, 27 had a pathogen zymodeme (PZ) while 54 had a non pathogen zymodeme (NPZ). Values obtained by IHA varied from negative to titres up to 1:256 in serum samples tested. Reactivity to E. histolytica antigens determined by EITB was observed in all sera. Patterns of antigen recognition were complex and showed reactivity to several parasite molecules. Among these, components with M. Wt. of 165, 119, and doublets of 98-100 and 50-52 Kd were more frequently recognized by antibodies present in the sera tested. In general, antibody titres detected by IHA did not showed a direct correlation with zymodeme analysis. Samples with PZ or NPZ had similar variable levels of reactivity to E. histolytica antigens.(ABSTRACT TRUNCATED AT 250 WORDS)
人类阿米巴病是一种寄生虫感染,在感染溶组织内阿米巴的个体中,它涉及无症状阶段以及肠道和肠外症状阶段。已经提出了几个因素来解释该疾病结果的变异性。其中包括溶组织内阿米巴菌株毒力的差异,并且诸如酶谱分析等方法已被用于区分该寄生虫的侵袭性菌株和非侵袭性菌株(萨金特和威廉姆斯,1978年)。为了在人类阿米巴病病例中建立酶谱分析与血清学数据之间的可能关联,在墨西哥克雷塔罗州卡德雷塔的社区区域进行了一项横断面流行病学研究。在这项研究中,还通过间接血凝试验(IHA)检测个体的粪便和血清样本以确定抗体滴度,并通过标准化的电免疫转移印迹试验(EITB)识别溶组织内阿米巴特异性抗原。总共对81个样本进行了酶谱测定。其中,27个具有病原体酶谱(PZ),而54个具有非病原体酶谱(NPZ)。在所检测的血清样本中,IHA获得的值从阴性到滴度高达1:256不等。在所有血清中均观察到通过EITB测定的对溶组织内阿米巴抗原的反应性。抗原识别模式复杂,显示出对几种寄生虫分子的反应性。其中,分子量为165、119以及98 - 100和50 - 52 Kd的双峰的成分更常被所检测血清中的抗体识别。一般而言,IHA检测到的抗体滴度与酶谱分析没有直接相关性。具有PZ或NPZ的样本对溶组织内阿米巴抗原的反应性水平相似且各不相同。(摘要截短于250字)